Local pharmaceutical manufacturing sits at the intersection of industrial policy, health security, and commercial viability. Strategy has to hold all three.
We led a diagnostic assessment of the sector, identifying the structural constraints limiting local production and the growth opportunities available to it. The recommendations addressed how to strengthen local manufacturing capacity, improve competitiveness, and build resilience into supply.